Literature DB >> 9343262

Export of hepatitis B virus RNA on a Rev-like pathway: inhibition by the regenerating liver inhibitory factor IkappaB alpha.

J Roth1, M Dobbelstein.   

Abstract

Nuclear export of hepatitis B virus (HBV) RNA is mediated by a specific RNA element but, in contrast to lentivirus genomic RNA, does not depend on viral proteins. We show that nonetheless, the export of HBV RNA can be blocked by competitive inhibitors of Rev-mediated lentivirus RNA export, suggesting that the export pathways of both viral species share components and might be driven by the same nuclear export machinery. HBV RNA export is also inhibited by overexpression of IkappaB alpha, as reported previously for the export of human immunodeficiency virus RNA. Since IkappaB alpha is strongly overexpressed during liver regeneration, its inhibition of HBV RNA export might contribute to elimination or silent persistence of HBV.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343262      PMCID: PMC192368     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport.

Authors:  L E Babiss; H S Ginsberg; J E Darnell
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

Review 2.  NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.

Authors:  M Grilli; J J Chiu; M J Lenardo
Journal:  Int Rev Cytol       Date:  1993

Review 3.  Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system.

Authors:  H C Liou; D Baltimore
Journal:  Curr Opin Cell Biol       Date:  1993-06       Impact factor: 8.382

4.  Proliferative activity of hepatocytes in chronic viral hepatitis as revealed by immunohistochemistry for proliferating cell nuclear antigen.

Authors:  T Nakamura; M Hayama; T Sakai; M Hotchi; E Tanaka
Journal:  Hum Pathol       Date:  1993-07       Impact factor: 3.466

5.  Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff.

Authors:  D N Halbert; J R Cutt; T Shenk
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

6.  I kappa B alpha can localize in the nucleus but shows no direct transactivation potential.

Authors:  D E Cressman; R Taub
Journal:  Oncogene       Date:  1993-09       Impact factor: 9.867

7.  Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: a study of proliferating cell nuclear antigen expression.

Authors:  H K Wolf; G K Michalopoulos
Journal:  Hepatology       Date:  1992-04       Impact factor: 17.425

8.  Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm.

Authors:  S Piñol-Roma; G Dreyfuss
Journal:  Nature       Date:  1992-02-20       Impact factor: 49.962

9.  The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs.

Authors:  S Pilder; M Moore; J Logan; T Shenk
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

10.  Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus.

Authors:  U Zabel; T Henkel; M S Silva; P A Baeuerle
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

View more
  20 in total

1.  A novel transferable nuclear export signal mediates CRM1-independent nucleocytoplasmic shuttling of the human cytomegalovirus transactivator protein pUL69.

Authors:  P Lischka; O Rosorius; E Trommer; T Stamminger
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

2.  Sox10 is an active nucleocytoplasmic shuttle protein, and shuttling is crucial for Sox10-mediated transactivation.

Authors:  Stephan Rehberg; Peter Lischka; Gabi Glaser; Thomas Stamminger; Michael Wegner; Olaf Rosorius
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

3.  The UL69 transactivator protein of human cytomegalovirus interacts with DEXD/H-Box RNA helicase UAP56 to promote cytoplasmic accumulation of unspliced RNA.

Authors:  Peter Lischka; Zsolt Toth; Marco Thomas; Regina Mueller; Thomas Stamminger
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

4.  Biological characterization of Rev variation in equine infectious anemia virus.

Authors:  M Belshan; M E Harris; A E Shoemaker; T J Hope; S Carpenter
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Nucleocytoplasmic shuttling and CRM1-dependent MHC class I peptide presentation of human cytomegalovirus pp65.

Authors:  Nadine Frankenberg; Peter Lischka; Sandra Pepperl-Klindworth; Thomas Stamminger; Bodo Plachter
Journal:  Med Microbiol Immunol       Date:  2012-09-11       Impact factor: 3.402

6.  The nuclear export signal within the E4orf6 protein of adenovirus type 5 supports virus replication and cytoplasmic accumulation of viral mRNA.

Authors:  S Weigel; M Dobbelstein
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element.

Authors:  J E Donello; J E Loeb; T J Hope
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

8.  A new RNA element located in the coding region of a murine endogenous retrovirus can functionally replace the Rev/Rev-responsive element system in human immunodeficiency virus type 1 Gag expression.

Authors:  H Wodrich; J Bohne; E Gumz; R Welker; H G Kräusslich
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors.

Authors:  M Gasmi; J Glynn; M J Jin; D J Jolly; J K Yee; S T Chen
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Posttranscriptional regulatory elements enhance antigen expression and DNA vaccine efficacy.

Authors:  Jing Sun; Dingfeng Li; Yanling Hao; Yuwei Zhang; Wenling Fan; Jingjing Fu; Yunzhang Hu; Yong Liu; Yiming Shao
Journal:  DNA Cell Biol       Date:  2009-05       Impact factor: 3.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.